Medicare Enrolled

Brandi Joyner, FNP

Nurse Practitioner - Primary Care · Longview, TX
300 N 3RD ST, Longview, TX 75601
9033152907
Registered in NPPES since 2021
NPI: 1821769381 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Joyner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Joyner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Joyner

Brandi Joyner is a nurse practitioner - primary care in Longview, TX, with 4 years of NPI registration.

Between the years covered by Open Payments, Joyner received a total of $8,912 from 49 pharmaceutical and/or device companies across 384 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Joyner is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 4 years of NPI registration $8,912 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$8,912
Total received (2021-2024)
Avg $2,228/year across 4 years
Top 1% in TX for nurse practitioner - primary care
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
384
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,267
2023
$2,837
2022
$2,150
2021
$658

Payments by company (2024)

GlaxoSmithKline, LLC.
$396
ABBVIE INC.
$392
AstraZeneca Pharmaceuticals LP
$379
Novo Nordisk Inc
$263
Bayer Healthcare Pharmaceuticals Inc.
$200
Amgen Inc.
$193
Inspire Medical Systems, Inc.
$136
GENZYME CORPORATION
$129
ViiV Healthcare Company
$118
Vanda Pharmaceuticals Inc.
$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$107
Astellas Pharma US Inc
$90
PFIZER INC.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Xeris Pharmaceuticals, Inc.
$75
Boston Scientific Corporation
$70
Axsome Therapeutics, Inc.
$66
Otsuka America Pharmaceutical, Inc.
$64
AIMMUNE THERAPEUTICS, INC.
$49
Sumitomo Pharma America, Inc.
$41
Lilly USA, LLC
$38
Mylan Specialty L.P.
$36
Aurinia Pharma U.S., Inc.
$27
Phathom Pharmaceuticals, Inc.
$21
IDORSIA PHARMACEUTICALS US INC
$21
Corcept Therapeutics
$17
Amneal Pharmaceuticals LLC
$17
SANOFI-AVENTIS U.S. LLC
$14
Neurocrine Biosciences, Inc.
$14
Lundbeck LLC
$14
Medicure Pharma Inc.
$13
Top 3 companies account for 35.7% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,120
AstraZeneca Pharmaceuticals LP
$947
GlaxoSmithKline, LLC.
$841
Novo Nordisk Inc
$757
Boehringer Ingelheim Pharmaceuticals, Inc.
$554
Lilly USA, LLC
$507
Bayer HealthCare Pharmaceuticals Inc.
$463
Bayer Healthcare Pharmaceuticals Inc.
$389
PFIZER INC.
$338
Amgen Inc.
$338
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$226
AbbVie Inc.
$189
IDORSIA PHARMACEUTICALS US INC
$171
Xeris Pharmaceuticals, Inc.
$165
Biohaven Pharmaceutical Holding Company Ltd.
$158
Otsuka America Pharmaceutical, Inc.
$146
Inspire Medical Systems, Inc.
$136
Mylan Specialty L.P.
$129
GENZYME CORPORATION
$129
ViiV Healthcare Company
$118
Boston Scientific Corporation
$113
Vanda Pharmaceuticals Inc.
$109
Astellas Pharma US Inc
$105
Axsome Therapeutics, Inc.
$80
Vifor Pharma, Inc.
$78
Nevro Corp.
$64
Novartis Pharmaceuticals Corporation
$50
AIMMUNE THERAPEUTICS, INC.
$49
Sumitomo Pharma America, Inc.
$41
Corcept Therapeutics
$38
NESTLE HEALTHCARE NUTRITION INC.
$37
Merck Sharp & Dohme LLC
$32
Aurinia Pharma U.S., Inc.
$27
Phathom Pharmaceuticals, Inc.
$21
Organon LLC
$21
Alkermes, Inc.
$20
Medtronic, Inc.
$20
ITI, Inc.
$19
Amneal Pharmaceuticals LLC
$17
UCB, Inc.
$16
Evoke Pharma, Inc.
$16
ACADIA Pharmaceuticals Inc
$16
Biogen, Inc.
$16
Banner Life Sciences, LLC
$16
Kowa Pharmaceuticals America, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$14
Neurocrine Biosciences, Inc.
$14
Lundbeck LLC
$14
Medicure Pharma Inc.
$13
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · APRETUDE · AREXVY · Auvelity · BAFIERTAM · BAQSIMI · BELSOMRA · BREZTRI · Briviact · CAPLYTA · CREON · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FANAPT · FARXIGA · FASENRA · GEMTESA · GIMOTI · GVOKE HYPOPEN · GVOKE PFS · INGREZZA · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · JANUVIA · JARDIANCE · KEVZARA · Kerendia · Korlym · LEQVIO · LINZESS · LUPKYNIS · LYBALVI · Livalo · MOUNJARO · NEXPLANON · NUPLAZID · NURTEC ODT · OFEV · Omnia · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RINVOQ · RYBELSUS · RYTARY · Repatha · Rybelsus · SHINGRIX · STIOLTO RESPIMAT · SYNJARDY · Senza · TRELEGY ELLIPTA · TRULICITY · TZIELD · UBRELVY · VOQUEZNA · VRAYLAR · Veltassa · Veozah · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XIFAXAN · YUPELRI · Yupelri · ZENPEP · Zypitamag
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - primary care in Longview?
Compare nurse practitioner - primary cares in the Longview area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares in nearby ZIP areas
7
County median income
$64,809
Nearest hospital to ZIP centroid (approximate)
CHRISTUS GOOD SHEPHERD MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Joyner is a nurse practitioner - primary care.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Joyner receive payments from pharmaceutical companies?
Yes. Joyner received a total of $8,912 from 49 companies across 384 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Joyner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Nurse Practitioner - Primary Cares in Longview
Browse nurse practitioner - primary cares in Longview ranked by procedure volume and transparency data.
Highest volume
Top Nurse Practitioner - Primary Cares in TX
Nurse practitioner - primary cares ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nurse Practitioner - Primary Cares in TX
Which TX nurse practitioner - primary cares receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →